Journal of Carcinogenesis & Mutagenesis

About the Journal

NLM ID: 101612108

Index Copernicus Value: 89.57


The Journal of Carcinogenesis & Mutagenesis is a peer-reviewed medical journal in cancer biology. This Scientific Journal focuses on the recognition of cellular responses to DNA damage, apoptosis (cell death), and inactivation of tumor suppressor genes and analysis of the carcinogenic process by genetic and epigenetic alterations in genes for the study of cancer initiation and progression.

This journal encompasses all the recent issues related to mutation and carcinogenesis under its scope. This includes understanding general cancer cell structure, detection techniques such as application of CAM assay, desmoplastic reaction, application of different therapeutic approaches such as the inhibitor of apoptosis (IAP), retinoid therapy and use of SPARC (secreted protein acidic and rich in cysteine) protein, c-Met inhibitor, other related medical conditions including epidermal pigment, photocarcinogenesis, lymphomatous polyposis, genotoxic carcinogen, ductal adenocarcinoma, adenocarcinoma pancreas prognosis, cancer epidemiology, tumors of pancreas, adenocarcinoma of stomach, etc.

Journal of Carcinogenesis & Mutagenesis always makes valuable research advancements available in the field of Carcinogenesis and Mutagenesis and thereby stands forward among the world famous Carcinogenesis journals and Mutagenesis journals.

Authors are encouraged to share their ideas and valuable research outcomes through this platform and provide the global readers updated and most important information in the mode of original articles, review articles, case reports, short communications, etc. Top quality articles are expected from the global research community which will aid in achieving high impact factor.

This scientific journal is using Editorial Manager System for quality in peer review process. Review processing is performed by the editorial board members of Journal of Carcinogenesis & Mutagenesis or outside experts; at least two independent reviewers approval followed by editor’s approval is required for acceptance of any citable manuscript

You may submit your manuscript as an e-mail attachment to manuscripts@walshmedicalmedia.com

Fast Editorial Execution and Review Process (FEE-Review Process):
Journal of Carcinogenesis & Mutagenesis is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.

Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.

The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.